The IDF Diabetes Complications Congress 2020 brings together members from around the world who are renowned experts in their fields. This ensures a programme of top quality and reflects the truly global nature of IDF Congresses.
Online abstract submission opens on 1 June and closes on 31 July 2020. The IDF Diabetes Complications Congress 2020 welcomes original abstracts on subjects relevant to the following diabetes complications topics:
Programme Chair: Professor João Filipe Raposo, Portugal
Professor João Raposo graduated in Medicine at the University of Lisbon and received his PhD in Endocrinology from the New University of Lisbon. He did his residency in Endocrinology at the Portuguese Cancer Institute from 1991 to 1997 and has been Consultant of Endocrinology at APDP since 2006. He is currently Assistant Professor of Public Health in the Medical Faculty of New University of Lisbon (NOVA Medical School) and a member of the Board of the Mediterranean Group for the Study of Diabetes (MGSD).
Cardiovascular Disease & Hypertension Stream: Professor Naveed Sattar, United Kingdom
Professor Naveed Sattar graduated from the University of Glasgow in 1990. In 1993 he moved to Glasgow Royal Infirmary, first as a Specialist Registrar then as Senior Lecturer and Reader. He was awarded a PhD from the University of Glasgow in 1998. He joined the staff of the University of Glasgow and in early 2005 was appointed as Professor of Metabolic Medicine at the Institute of Cardiovascular & Medical Sciences. He continues as an Honorary Consultant at the Glasgow Royal Infirmary, where he co-leads a CVD prevention clinic. He is a Fellow of the Royal College of Pathologists, the Royal College of Physicians and Surgeons, Glasgow, the Royal Society of Edinburgh and the UK Academy of Medical Sciences.
Eye & Kidney: Per-Henrik Groop, Finland
Professor Per-Henrik Groop, MD, DMSc, FRCPE graduated from the University of Helsinki in 1982. Following post-doctoral studies at Guy’s Hospital, University of London, under Professor Giancarlo Viberti, Professor Groop returned to Helsinki as Consultant of Nephrology. He served as Professor of Nephrology (Chair) 2010–2015 and is currently Professor of Internal Medicine (Chair) at the University of Helsinki. He is also Chief Physician at the Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital and Principal Investigator of the Finnish Diabetic Nephropathy (FinnDiane) Study at the Folkhälsan Research Center in Helsinki, Finland. He is Adjunct Professor at the Department of Diabetes, Monash University, Melbourne, Australia.
Foot & Neuropathy: Andrew Boulton, United Kingdom
Professor Andrew Boulton is President of the International Diabetes Federation (IDF) for 2020-21. He also currently serves as President of the Worldwide Initiative for Diabetes Education and Chair of EURADIA (European Alliance for Diabetes Research). Professor Boulton is a graduate of Newcastle-upon-Tyne University. He subsequently trained in Sheffield and Miami prior to accepting an appointment at Manchester University, where he is currently Professor of Medicine with a special interest in diabetes and its complications. He is also Consultant Physician at Manchester Royal Infirmary.
Programme Committee Overview
Stream Descriptions and Learning Objectives
Cardiovascular Disease & Hypertension Stream
This stream focuses on all aspects of cardiovascular disease in relation to diabetes, both prevention and treatment of people with diabetes and existing cardiovascular disease, or heart failure. All aspects of the cardiovascular disease will be covered including epidemiology, screening processes and organisation of such care, diagnosis and latest management, with data from both high, and low and middle income countries welcomed. Therapy areas could include lifestyle factors, established cardiovascular risk reduction therapies and anti-diabetic medicines.
After attending sessions in the Cardiovascular Disease & Hypertension stream, the participant will be able to:
Understand the main risk factors for cardiovascular risk in diabetes
The drivers towards heart failure in diabetes, and how these compare and contrast those with coronary heart disease
Understand that treatment of lipids and blood pressure has substantial benefits in diabetes and, where relevant, to discuss appropriate treatment targets
Understand how processes of care can be simplified to aid cardiovascular risk reduction in diabetes
Understand the evidence-based treatments designed to lower glucose now available for lessening cardiovascular disease
Apply the evidence-based research to the management of cardiovascular disease and heart failure in diabetes
Eye & Kidney Stream
This stream focuses on clinically important aspects of the devastating late complications diabetic retinopathy and diabetic nephropathy (kidney disease). The stream will highlight how common eye and kidney disease are and what the consequences are; how to identify the individuals with these complications early enough to be able to treat and improve the prognosis of the affected individuals; why these complications affect a subset of individuals with diabetes; how to treat eye and kidney disease with “standard-of-care” tools and how to implement novel treatment options; how eye and kidney complications affect the adherence to treatment as well as the psychological well-being not only from the “care provider’s” but also from the “patient’s” perspective.
After attending sessions in the Eye & Kidney stream, the participant will be able to understand:
How to screen for diabetic eye and kidney disease with currently available tools and what potential new tools there are emerging
How common eye and kidney disease are and what are the consequences for an individual with these complications
Why some people with diabetes develop eye and kidney disease while others do not
How to treat eye and kidney disease according to standard of care but also to become familiar with the promising novel treatments to reduce the burden of these complications
Foot & Neuropathy Stream
This stream focuses on all aspects of diabetic neuropathy including both somatic and autonomic. It will also focus largely on lower limb problems in diabetes particularly neuropathy, peripheral arterial disease, and diabetic foot disease. Within the last of these will be an included section on Charcot neuroarthropathy. All aspects of the neuropathies and diabetic foot problems will be covered including epidemiology, screening, diagnosis and latest management. In the area of the diabetic foot a major section will be on prevention of amputation and early management of diabetic foot infections.
After attending sessions in the Foot & Neuropathy stream, the participant will be able to:
Understand the multiple manifestations of neuropathy both somatic and autonomic.
Understand that early diagnosis of neuropathy by screening is advocated in the prevention of later complications
Understand that there are no cures for somatic or autonomic neuropathy, but many treatments which will be outlined in the stream
Achieve a broad understanding of the pathogenesis and potential prevention of diabetic foot problems
Understand the evidence base treatments now available for managing diabetic foot problems and foot infections
Apply the evidence-based research to the management of neuropathy and foot problems in day to day clinical practice
Session Topics Overview
Cardiovascular Disease & Hypertension
Aspirin should be reserved for secondary prevention in type 2 diabetes
Home blood pressure is as predictive as ambulatory blood pressure monitoring for cardiovascular outcomes
Cardiovascular disease risks in diabetes across the globe: what have we learned?
Heart failure and diabetes: diagnosis and phenotypes
Heart failure and diabetes: risk factors and novel treatments
Masterclass on lipids in diabetes
Risk prediction and coronary artery disease in diabetes
Weight loss, lifestyle and Cardiovascular disease risks in diabetes
Eye & Kidney
Diabetic eye and other complications of diabetes
Management of diabetic eye diseases
How do individuals with diabetes cope with late complications?
Non-attendance at diabetic screening events
How should I screen for diabetic kidney disease?
How should I treat individuals with diabetic kidney disease?
Pathogenesis and pathophysiology of diabetic eye disease
Screening for diabetic retinopathy
Why do some individuals with diabetes develop kidney disease?
The magnitude of the problem – eye and kidney disease